95 Participants NeededMy employer runs this trial

Pulsed Radiofrequency for Neuropathic Pain

Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to examine non-invasive pulsed radiofrequency (NIPRF) and the effect it has on chronic neuropathic pain. Chronic neuropathic pain after peripheral nerve injury most often occurs in the context of post-traumatic or post-surgical pain. It is often treated with nerve blocks, prescription medication, physical therapy, neuromodulation, and surgery. The study team will be examining the efficacy of NIPRF and determining if it would be an appropriate treatment for chronic neuropathic pain after peripheral nerve injury.The Stimpod used in the present study is FDA approved and will be used for on label purposes.

Are You a Good Fit for This Trial?

Inclusion Criteria

I had at least 50% pain relief after a nerve block test.
I have had ongoing pain for at least 12 weeks despite standard treatments.
My pain level at the affected site is 5 or higher out of 10.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Invasive Pulsed Radiofrequency

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: Active TreatmentActive Control1 Intervention
Group II: Non-Active TreatmentPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+